Delivery Order SPE2DB24D1201-SPE2DB25FJDUX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $14,661.05. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $1,833.32 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a $10,405.72 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order represents a single transaction under AmerisourceBergen Drug Corp's broader federal contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $7,807.46 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $3,803.41 to AmerisourceBergen Drug Corp for the supply of Forteo 560 MCG/2.24 ML pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a direct delivery order for pharmaceutical products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,833.32 on September 3, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is set to complete by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDUXDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo 560 micrograms per 2.24 milliliter pen injections with a ceiling value of $13,658.50. This firm fixed price, non-set-aside delivery order is scheduled for ultimate completion by August 8, 2025, with performance originating from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial pharmaceutical distribution support to the federal government through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen's role as a prime pharmaceutical vendor underscores its strategic importance in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 8/7/25 |